North Square Disciplined Value ETF
NSIV - ETF AI Analysis
Top Page
North Square Disciplined Value ETF (NSIV)
NSIV, the North Square Disciplined Value ETF, has a solid overall rating driven mainly by strong, cash-generative holdings like Verizon, Microsoft, and Shell, which combine attractive valuations with positive long-term business outlooks. Financial firms such as US Bancorp and Citigroup also support the fund’s quality, though names like AbbVie and Altria introduce some drag due to leverage, profitability, and technical concerns. The main risk factor is the fund’s meaningful exposure to large financial and value-oriented companies, which can be sensitive to economic cycles and market sentiment.
NSIV vs. SPDR S&P 500 ETF (SPY)
- AUM
- 74.13M
- Region
- North America
- Expense Ratio
- 0.38%
- Beta
- 0.34
- Issuer
- North Square
- Inception Date
- Jul 09, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
NSIV Summary
The North Square Disciplined Value ETF (NSIV) is a U.S. stock fund that focuses on large, established companies considered “value” stocks—businesses that appear reasonably priced based on their earnings and cash flow. It doesn’t track a single index, but aims to beat the Russell 1000 Value Index by carefully selecting and diversifying across sectors like financials, technology, health care, and energy. Well-known holdings include Amazon and Apple. Investors might consider NSIV for long-term growth with a value tilt and broad sector diversification. A key risk is that its stock prices can rise and fall with the overall market and value stocks can lag for long periods.
How much will it cost me?
This ETF has an expense ratio of 0.38%, which means you’ll pay about $3.80 per year for every $1,000 invested. That’s a bit higher than the average low-cost index ETF because this fund is actively managed, using research and stock selection to try to beat a value index over time.
What would affect this ETF?
This ETF focuses on large U.S. companies in sectors like financials, technology, health care, and energy, so it could benefit if the U.S. economy stays resilient, corporate profits grow, and value-style stocks come back into favor, especially for its big tech and financial holdings like Apple, Microsoft, Amazon, and major banks. On the other hand, rising interest rates, a U.S. recession, tighter banking regulations, or weak performance in energy and communication services could hurt the fund, and its active stock-picking approach may lag if value stocks or its chosen sectors fall out of favor.
NSIV Top 10 Holdings
NSIV leans into classic large-cap value, with U.S. financials and health care doing much of the heavy lifting. Shell has been a standout, rising on strong energy markets and giving the fund a solid boost, while Pfizer and AbbVie add steady, improving momentum from the defensive health care side. Microsoft and Amazon bring a dash of Big Tech growth to the mix, helping performance without dominating the story. On the flip side, Verizon and Citigroup have been lagging, acting like mild headwinds in an otherwise broadly diversified, U.S.-focused value portfolio.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 MSFT | Microsoft | 4.68% | $3.49M | $3.96T | 2.45% | 79Outperform |
 VZ | Verizon | 3.58% | $2.68M | $191.94B | 14.50% | 81Outperform |
 USB | US Bancorp | 3.37% | $2.52M | $94.66B | 27.47% | 76Outperform |
 PFE | Pfizer | 3.22% | $2.40M | $167.35B | 15.44% | 74Outperform |
 MO | Altria Group | 2.93% | $2.19M | $126.99B | 32.49% | 64Neutral |
 ABBV | AbbVie | 2.92% | $2.18M | $519.48B | 31.00% | 66Neutral |
 HIG | Hartford Insurance | 2.90% | $2.17M | $36.85B | 4.58% | 78Outperform |
 SHEL | Shell | 2.56% | $1.91M | $272.74B | 27.07% | 78Outperform |
 C | Citigroup | 2.42% | $1.81M | $205.10B | 23.27% | 68Neutral |
 AMZN | Amazon | 2.56% | $1.91M | $2.93T | 6.85% | 71Outperform |
NSIV Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NSIV, the sentiment is Positive. The current price of 26.24 is above the 20-day moving average (MA) of 26.07, above the 50-day MA of 25.89, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.05 indicates Positive momentum. The RSI at 55.81 is Neutral, neither overbought nor oversold. The STOCH value of 59.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NSIV.
NSIV Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| NSIV | $26.24 | $29.00(10.51% Upside) | $74.13M | 0.38% | 72Outperform |
 PRXV | $36.94 | $42.32(14.57% Upside) | $96.98M | 0.36% | 72Outperform |
 MAVF | $141.69 | $168.26(18.75% Upside) | $93.47M | 0.75% | 75Outperform |
 PZLV | $32.36 | $36.08(11.49% Upside) | $73.80M | 0.60% | 67Neutral |
 DHLX | $14.29 | $16.31(14.20% Upside) | $73.87M | 0.55% | 73Outperform |
 MDLV | $32.21 | $34.66(7.59% Upside) | $48.31M | 0.58% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| NSIV | North Square Disciplined Value ETF | 26.24 | 1.16 | 4.61% | |
| PRXV | Praxis Impact Large Cap Value ETF | 36.94 | 7.76 | 26.58% | |
| MAVF | Matrix Advisors Value ETF | 141.69 | 25.41 | 21.86% | |
| PZLV | Pzena U.S. Large Cap Value ETF | 32.36 | 7.26 | 28.92% | |
| DHLX | Diamond Hill Large Cap Concentrated ETF | 14.29 | 1.60 | 12.57% | |
| MDLV | Morgan Dempsey Large Cap Value ETF | 32.21 | 4.84 | 17.67% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.